Table 3.
Efficacy results during the first 12 months after kidney transplantation (n = 58)
| Parameters | Values |
|---|---|
| BPAR, n (%) | 14 (24.1) |
| IA | 2 (3.4) |
| IB | 4 (6.9) |
| IIA | 3 (5.2) |
| IIB | 3 (5.2) |
| III | 2 (3.4) |
| AMR, n (%) | 6 (10.3) |
| AR treatment failure, n (%) | 4 (6.9) |
| DGF, n (%) | 13 (22.4) |
| Graft loss, n (%) | 8 (13.8) |
| Death, n (%) | 6 (10.3) |
| Graft survival (%) | 50 (86.2) |
| Patient survival (%) | 52 (89.7) |
| Serum creatinine (µmol/L) | 112 ± 23.2 |
| eGFR (ml/min; Cockcroft–Gault) | 58.4 ± 13.9 |
Data was presented as mean ± SD or n (%). AR: Acute rejection; AMR: Antibody-mediated rejection; BPAR: Biopsy-proven acute rejection; DGF: Delayed graft function; eGFR: Estimated glomerular filtration rate.